The number of stem cell transplants performed is increasing, which means more people are concerned about ongoing complications or late effects after transplant. This presentation reviews potential late effects after a stem cell transplant (hematopoietic cell transplant) using donor cells (aka allogeneic transplant).
Las personas que se someten a un trasplante de médula ósea/células madre utilizando células de un donante (trasplante alogénico) generalmente se curan, pero pueden tener efectos secundarios persistentes o que aparecen tardíamente.
Download Speaker Slides Spanish Translation Coming Soon Late Effects after a Transplant Using Donor Cells (Allogeneic Transplant) April 17, 2021 Presenter: Catherine Lee, MD, Assistant Professor of Medicine in Division